Raymond James & Associates’s First Trust Multi Cap Value AlphaDEX Fund FAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$905K Buy
10,707
+537
+5% +$44.1K ﹤0.01% 2756
2024
Q2
$801K Buy
10,170
+3,040
+43% +$242K ﹤0.01% 2779
2024
Q1
$589K Sell
7,130
-557
-7% -$43.3K ﹤0.01% 2965
2023
Q4
$600K Sell
7,687
-104
-1% -$7.41K ﹤0.01% 2838
2023
Q3
$543K Sell
7,791
-1,743
-18% -$127K ﹤0.01% 2836
2023
Q2
$676K Sell
9,534
-1,778
-16% -$121K ﹤0.01% 2729
2023
Q1
$788K Sell
11,312
-83
-0.7% -$6.01K ﹤0.01% 2620
2022
Q4
$784K Sell
11,395
-4,410
-28% -$301K ﹤0.01% 2574
2022
Q3
$961K Buy
15,805
+2,420
+18% +$165K ﹤0.01% 2417
2022
Q2
$877K Buy
13,385
+4,037
+43% +$288K ﹤0.01% 2534
2022
Q1
$698K Buy
9,348
+1,367
+17% +$102K ﹤0.01% 2849
2021
Q4
$600K Sell
7,981
-150
-2% -$11K ﹤0.01% 2953
2021
Q3
$570K Buy
8,131
+232
+3% +$16.5K ﹤0.01% 2971
2021
Q2
$561K Sell
7,899
-204
-3% -$14.7K ﹤0.01% 3003
2021
Q1
$559K Sell
8,103
-1,083
-12% -$69.9K ﹤0.01% 2939
2020
Q4
$535K Buy
9,186
+314
+4% +$16.8K ﹤0.01% 2765
2020
Q3
$412K Sell
8,872
-440
-5% -$21K ﹤0.01% 2762
2020
Q2
$428K Sell
9,312
-3
-0% -$128 ﹤0.01% 2697
2020
Q1
$332K Sell
9,315
-879
-9% -$44.1K ﹤0.01% 2701
2019
Q4
$592K Sell
10,194
-91
-0.9% -$5.03K ﹤0.01% 2608
2019
Q3
$549K Sell
10,285
-239
-2% -$12.6K ﹤0.01% 2582
2019
Q2
$567K Buy
10,524
+288
+3% +$15.5K ﹤0.01% 2570
2019
Q1
$551K Buy
10,236
+110
+1% +$5.84K ﹤0.01% 2589
2018
Q4
$484K Buy
10,126
+120
+1% +$6.36K ﹤0.01% 2569
2018
Q3
$576K Buy
10,006
+1,472
+17% +$84.7K ﹤0.01% 2615
2018
Q2
$480K Sell
8,534
-2,719
-24% -$151K ﹤0.01% 2722
2018
Q1
$615K Sell
11,253
-1,495
-12% -$84.3K ﹤0.01% 2443
2017
Q4
$726K Sell
12,748
-2,870
-18% -$158K ﹤0.01% 2308
2017
Q3
$838K Buy
15,618
+6,121
+64% +$320K ﹤0.01% 2200
2017
Q2
$497K Buy
9,497
+181
+2% +$9.35K ﹤0.01% 2426
2017
Q1
$484K Sell
9,316
-2,116
-19% -$109K ﹤0.01% 2398
2016
Q4
$577K Sell
11,432
-714
-6% -$34.2K ﹤0.01% 2252
2016
Q3
$553K Buy
12,146
+1,646
+16% +$73.8K ﹤0.01% 2207
2016
Q2
$446K Sell
10,500
-24,046
-70% -$1.03M ﹤0.01% 2168
2016
Q1
$1.49M Sell
34,546
-2,757
-7% -$108K 0.01% 1458
2015
Q4
$1.52M Buy
37,303
+17,631
+90% +$748K 0.01% 1410
2015
Q3
$801K Sell
19,672
-292,537
-94% -$12.7M ﹤0.01% 1710
2015
Q2
$14.5M Buy
312,209
+238,862
+326% +$11.5M 0.06% 389
2015
Q1
$3.49M Buy
73,347
+15,216
+26% +$716K 0.02% 928
2014
Q4
$2.75M Buy
58,131
+22,499
+63% +$1.03M 0.01% 989
2014
Q3
$1.61M Buy
35,632
+14,299
+67% +$669K 0.01% 1206
2014
Q2
$1.02M Buy
21,333
+335
+2% +$15.4K 0.01% 1487
2014
Q1
$959K Sell
20,998
-4,625
-18% -$204K 0.01% 1449
2013
Q4
$1.14M Buy
25,623
+3,894
+18% +$166K 0.01% 1255
2013
Q3
$878K Buy
21,729
+9,888
+84% +$394K 0.01% 1324
2013
Q2
$448K Buy
+11,841
New +$443K ﹤0.01% 1561

Other funds holding FAB

Raymond James & Associates's FAB Position: Q3 2024 in Review

Raymond James & Associates increased its First Trust Multi Cap Value AlphaDEX Fund (FAB) stake by 5.3% in Q3 2024, buying an estimated $44.1K and bringing the position to 10,707 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #2756.

Raymond James & Associates first reported a position in FAB in Q2 2013 and has held it in 46 quarters since. The position peaked at $14.5M in Q2 2015. 64 funds tracked by Wall St. Rank hold FAB as of Q3 2024.

  • Raymond James & Associates held 10,707 shares of First Trust Multi Cap Value AlphaDEX Fund worth $905K as of Q3 2024.
  • Raymond James & Associates bought 537 First Trust Multi Cap Value AlphaDEX Fund shares in Q3 2024, an estimated $44.1K.
  • First Trust Multi Cap Value AlphaDEX Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2756 holding.
  • Raymond James & Associates first reported a position in First Trust Multi Cap Value AlphaDEX Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's First Trust Multi Cap Value AlphaDEX Fund position peaked at $14.5M in Q2 2015.
  • 64 funds tracked by Wall St. Rank held First Trust Multi Cap Value AlphaDEX Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.